Research output per year
Research output per year
Search results
-
2025
Informed Consent Procedure for Research Including Patients with Parkinson's Disease and Cognitive Impairment
Sisodia, V., Swinnen, B. E. K. S., Lemstra, E., Geurtsen, G. J., Leentjens, A. F. G., Buijsen, M. A. J. M., Schermer, M. H. N. & de Bie, R. M. A., 2025, (E-pub ahead of print) In: Movement Disorders Clinical Practice.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Temporal and biological heterogeneity in Lewy body disease
Lemstra, A. W. & van de Berg, W. D. J., 1 May 2025, In: Lancet Neurol.. 24, 5, p. 378-379 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
2023
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)
EADB contributors, GR@ACE study group, DEGESCO consortium, IGAP (ADGC, CHARGE, EADI, GERAD) & PGC-ALZ consortia, Dec 2023, In: Nature communications. 14, 1, p. 716 716.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile1 Downloads (Pure) -
2022
Erratum: Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. Cells 2021, 10, 38 (Cells (2020) 10 1 PII: 652)
Boiten, W. A., van Steenoven, I., Xiao, M.-F., Worley, P. F., Noli, B., Cocco, C., Ferri, G.-L., Lemstra, A. W. & Teunissen, C. E., 14 Feb 2022, In: Cells. 11, 4Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile1 Downloads (Pure) -
2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8): A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB) & The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, 1 May 2020, In: Acta neuropathologica. 139, 5, p. 959-962 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile1 Downloads (Pure) -
Parkinsonism and Bipolar Disorder
Dols, A. & Lemstra, A. W., 1 Jun 2020, In: Bipolar disorders. 22, 4, p. 413-415 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile1 Downloads (Pure) -
2003
Cholinesterase inhibitors for Alzheimer disease
van Gool, W. A. & Lemstra, A. W., 2003, In: JAMA. 289, 18, p. 2359-2359; author reply 2361Research output: Contribution to journal › Comment/Letter to the editor › Academic